Bulacan State University
COLLEGE OF NURSING
City of Malolos, Bulacan
DRUG STUDY
Patient’s Initial: ___I________ Age: __74______ Gender: __Male______ Date Handled: __Dec. 7, 2020___
Medical Diagnosis: __Heart Failure________________ Chief Complaint: __Worsening of heart failure_____ Clinical Area: ___N/A__________
Medications Date Ordered/ Route of Mechanism of Indication Contraindication Client’s Response Nursing Respo
Given or Administration/ Action
Taken/ Dosage/
Discontinued Frequency
Generic: Date Ordered: Route of - Increases - Edema - Contraindicated - The edema was eradicated Prior:
-hydrochlorothiazide - N/A Administration: sodium and in patients with because of the client’s urination. - Ask the client if he h
- N/A water excretion anuria and thiazides and sulfonam
Brand: Date by inhibiting patients Adverse Effect:
N/A Given/Taken: Dosage: sodium and hypersensitive to CNS: dizziness, vertigo, - Obtain complete heal
- N/A - 100 mg chloride other thiazides or headache, paresthesia, weakness, pulmonary and renal di
Classification: reabsorption in other sulfonamide restlessness. studies: CBC, BUN, cr
- Diuretics Date Frequency: distal segment derivatives. CV: orthostatic hypotension, electrolytes, PT, PTT,
Discontinued: - N/A of the nephron. vasculitis.
- N/A - Drugs can cause GI: anorexia, nausea, - Obtain vital signs, inc
systemic lupus pancreatitis, epigastric distress, pressure.
activation or vomiting, abdominal pain,
exacerbation. diarrhea, constipation. - Explain to the client o
GU: polyuria, frequent urination, the purpose of the med
- Used cautiously renal failure, interstitial nephritis.
in children and in Hematologic: aplastic anemia, - Educate the client or
patients with agranulocytosis, leukopenia, the possible side effect
severe renal thrombocytopenia, hemolytic medication
disease, impaired anemia.
hepatic function Hepatic: jaundice. During:
or progressive Metabolism: hypokalemia; - Give the medication
hepatic disease. asymptomatic hyperuricemia; prevent nocturia.
hyperglycemia and impaired
glucose tolerance; fluid and - Instruct the patient to
electrolyte imbalances, including medication with food t
dilutional hyponatremia, upset.
hypochloremia, metabolic
COLLEGE OF NURSING
City of Malolos, Bulacan
DRUG STUDY
Patient’s Initial: ___I________ Age: __74______ Gender: __Male______ Date Handled: __Dec. 7, 2020___
Medical Diagnosis: __Heart Failure________________ Chief Complaint: __Worsening of heart failure_____ Clinical Area: ___N/A__________
Medications Date Ordered/ Route of Mechanism of Indication Contraindication Client’s Response Nursing Respo
Given or Administration/ Action
Taken/ Dosage/
Discontinued Frequency
Generic: Date Ordered: Route of - Increases - Edema - Contraindicated - The edema was eradicated Prior:
-hydrochlorothiazide - N/A Administration: sodium and in patients with because of the client’s urination. - Ask the client if he h
- N/A water excretion anuria and thiazides and sulfonam
Brand: Date by inhibiting patients Adverse Effect:
N/A Given/Taken: Dosage: sodium and hypersensitive to CNS: dizziness, vertigo, - Obtain complete heal
- N/A - 100 mg chloride other thiazides or headache, paresthesia, weakness, pulmonary and renal di
Classification: reabsorption in other sulfonamide restlessness. studies: CBC, BUN, cr
- Diuretics Date Frequency: distal segment derivatives. CV: orthostatic hypotension, electrolytes, PT, PTT,
Discontinued: - N/A of the nephron. vasculitis.
- N/A - Drugs can cause GI: anorexia, nausea, - Obtain vital signs, inc
systemic lupus pancreatitis, epigastric distress, pressure.
activation or vomiting, abdominal pain,
exacerbation. diarrhea, constipation. - Explain to the client o
GU: polyuria, frequent urination, the purpose of the med
- Used cautiously renal failure, interstitial nephritis.
in children and in Hematologic: aplastic anemia, - Educate the client or
patients with agranulocytosis, leukopenia, the possible side effect
severe renal thrombocytopenia, hemolytic medication
disease, impaired anemia.
hepatic function Hepatic: jaundice. During:
or progressive Metabolism: hypokalemia; - Give the medication
hepatic disease. asymptomatic hyperuricemia; prevent nocturia.
hyperglycemia and impaired
glucose tolerance; fluid and - Instruct the patient to
electrolyte imbalances, including medication with food t
dilutional hyponatremia, upset.
hypochloremia, metabolic
